Cargando…

The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients

BACKGROUND: Early-stage amyloidosis of the heart is prone to be underdiagnosed or misdiagnosed, increasing the risk of early heart failure and even death of the patient. To ensure timely intervention for cardiac light-chain amyloidosis (AL CA), it is vital to develop an effective tool for early iden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yue, Xiuzheng, Yang, Lili, Wang, Rui, Chan, Queenie, Yang, Yanbing, Wu, Xiaohong, Ruan, Xiaowei, Zhang, Zhen, Wei, Yuping, Wang, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623184/ https://www.ncbi.nlm.nih.gov/pubmed/36330005 http://dx.doi.org/10.3389/fcvm.2022.1017097

Ejemplares similares

CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy
por: Wang, Fangqing, et al.
Publicado: (2023)

Differentiating between cardiac amyloidosis and hypertrophic cardiomyopathy on non-contrast cine-magnetic resonance images using machine learning-based radiomics
por: Jiang, Shu, et al.
Publicado: (2022)

Electrocardiogram Characteristics and Prognostic Value in Light-Chain Amyloidosis: A Comparison With Cardiac Magnetic Resonance Imaging
por: Guo, Xinli, et al.
Publicado: (2021)

Comparison of left ventricular global and segmental strain parameters by cardiovascular magnetic resonance tissue tracking in light-chain cardiac amyloidosis and hypertrophic cardiomyopathy
por: Wang, Fangqing, et al.
Publicado: (2022)

Amyloidosis with phenotype of hypertrophic cardiomyopathy
por: Kuryła, Martyna, et al.
Publicado: (2023)

Cardiovascular toxicity from therapies for light chain amyloidosis
por: Morfino, Paolo, et al.
Publicado: (2023)

Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance
por: Izquierdo, Cristian, et al.
Publicado: (2021)

Non-pharmaceutical Interventions for Hypertrophic Cardiomyopathy: A Mini Review
por: He, Miaomiao, et al.
Publicado: (2021)

The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy
por: Aguiar Rosa, Sílvia, et al.
Publicado: (2021)

COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021)

Prognostic Value of Circulating sST2 for the Prediction of Mortality in Patients With Cardiac Light-Chain Amyloidosis
por: Zhang, Yang, et al.
Publicado: (2021)

Cardiac Amyloidosis Masked as Hypertrophic Cardiomyopathy: A Case Report
por: Wang, Jing, et al.
Publicado: (2016)

Cardiac amyloidosis and hypertrophic cardiomyopathy: A dangerous liaison
por: Ebrille, Elisa, et al.
Publicado: (2013)

Mean Scar Entropy by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Associated With Ventricular Arrhythmias Events in Hypertrophic Cardiomyopathy
por: Ye, Yang, et al.
Publicado: (2021)

Significance and Determinants of Plasma Apelin in Patients With Obstructive Hypertrophic Cardiomyopathy
por: Yang, Chengzhi, et al.
Publicado: (2022)

Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment
por: Cheng, Zeyi, et al.
Publicado: (2021)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Myocardial Biopsy in a History of Light-Chain Amyloidosis Patient With Serial Cardiac Magnetic Resonance Imaging Not Suggestive of Cardiac Involvement
por: Mizutani, Hana, et al.
Publicado: (2019)

Magnetic Resonance Elastography of Liver in Light Chain Amyloidosis
por: Venkatesh, Sudhakar K., et al.
Publicado: (2019)

Texture analysis of T2-weighted cardiovascular magnetic resonance imaging to discriminate between cardiac amyloidosis and hypertrophic cardiomyopathy
por: Huang, Shan, et al.
Publicado: (2022)

Predictive value of cardiac magnetic resonance mechanical parameters for myocardial fibrosis in hypertrophic cardiomyopathy with preserved left ventricular ejection fraction
por: Hou, Xian, et al.
Publicado: (2022)

Global Circumferential Strain by Cardiac Magnetic Resonance Tissue Tracking Associated With Ventricular Arrhythmias in Hypertrophic Cardiomyopathy Patients
por: Pu, Cailing, et al.
Publicado: (2021)

Grade 3 myocardial uptake in (99m)technetium-pyrophosphate scintigraphy in light chain cardiac amyloidosis
por: Okada, Atsushi, et al.
Publicado: (2021)

Anxiety Predicts Poor Prognosis in Patients With Hypertrophic Cardiomyopathy
por: He, Chao-Jie, et al.
Publicado: (2022)

Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
por: Burkart, Valentin, et al.
Publicado: (2022)

Cardiovascular Imaging in Pregnancy: Valvulopathy, Hypertrophic Cardiomyopathy, and Aortopathy
por: Ismail, Haneen, et al.
Publicado: (2022)

Dual apical hypertrophic cardiomyopathy and endomyocardial fibrosis pathology
por: Martini, Chiara, et al.
Publicado: (2023)

Right Ventricle Outflow Obstruction in Biventricular Hypertrophic Cardiomyopathy in Amyloidosis
por: Sanoussi, Hamza, et al.
Publicado: (2017)

Hypertrophic Obstructive Cardiomyopathy: Comparison of Outcomes After Myectomy or Alcohol Ablation
por: Meng, Xiangbin, et al.
Publicado: (2022)

Twenty-four hour variability of inverted T-waves in patients with apical hypertrophic cardiomyopathy
por: Ma, Fei, et al.
Publicado: (2022)

Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018)

High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis
por: Li, Muzheng, et al.
Publicado: (2021)

Derivation and Validation of a Screening Model for Hypertrophic Cardiomyopathy Based on Electrocardiogram Features
por: Guo, Lanyan, et al.
Publicado: (2022)

Effect of Papillary Muscles and Trabeculae on Left Ventricular Measurement Using Cardiovascular Magnetic Resonance Imaging in Patients with Hypertrophic Cardiomyopathy
por: Park, Eun-Ah, et al.
Publicado: (2015)

Comprehensive Proteomics Profiling Identifies Patients With Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in the Hypertrophic Cardiomyopathy Population
por: Lander, Bradley S., et al.
Publicado: (2022)

Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment
por: Martinez-Naharro, Ana, et al.
Publicado: (2022)

Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis
por: Bak, Minjung, et al.
Publicado: (2022)

COVID-19 INFECTION IN A PATIENT WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
por: AFRAZ PASHA, MOHAMMED, et al.
Publicado: (2021)

Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era
por: Butzner, Michael, et al.
Publicado: (2022)

Further Considerations in Childhood-Onset Hypertrophic Cardiomyopathy Genetic Testing
por: Monasky, Michelle M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ql8vvaka8rbic5sgejbhl0e87q